To compare use of Relyvrio for treatment of amyotrophic lateral sclerosis (ALS) among general neurologists, ALS Center-affiliated neurologists (ALS-C) and neuromuscular specialists.
No takes yet. Share an insight, caveat, or question.
Cloud et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: